74 related articles for article (PubMed ID: 23797901)
1. Prevention of human papillomavirus-related malignancy: access is the answer.
Duska LR; Stoler MH
Cancer; 2013 Aug; 119(16):2953-5. PubMed ID: 23797901
[No Abstract] [Full Text] [Related]
2. [Identification and genotyping of oncogenic type of human papillomavirus in paraffin-embedded cervical cancer samples in Guangzhou].
Zeng L; Yu SY; Gou SQ; Yun JP; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2485-7. PubMed ID: 20034908
[TBL] [Abstract][Full Text] [Related]
3. Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty.
Niccolai LM; Russ C; Julian PJ; Hariri S; Sinard J; Meek JI; McBride V; Markowitz LE; Unger ER; Hadler JL; Sosa LE
Cancer; 2013 Aug; 119(16):3052-8. PubMed ID: 23661284
[TBL] [Abstract][Full Text] [Related]
4. High-risk HPV infection among the tribal and non-tribal women of the Andaman and Nicobar Islands, India.
Parvez R; Hedau S; Bhattacharya D; Bhattacharjee H; Muruganandam N; Das BC; Saha MK; Sugunan AP; Vijayachari P
Public Health; 2012 Jan; 126(1):67-9. PubMed ID: 22130478
[No Abstract] [Full Text] [Related]
5. Human papillomavirus genotyping in histological sections of precursor lesions of cervical carcinoma: its role as a possible adjunct for the evaluation of the oncogenic potential of specific human papillomavirus genotypes - a study in a coastal region of southeastern Spain.
Doménech-Peris A; Conesa-Zamora P; Sahuquillo-Frias L; Ortiz-Reina S; Moya-Biosca J; Acosta-Ortega J; Pérez-Guillermo M; Egea-Cortines M
Gynecol Obstet Invest; 2010; 70(2):113-9. PubMed ID: 20332645
[TBL] [Abstract][Full Text] [Related]
6. Preventing human papillomavirus disease.
Trimble CL
J Clin Oncol; 2012 Sep; 30(25):3037-8. PubMed ID: 22851562
[No Abstract] [Full Text] [Related]
7. Human papillomavirus prevalence in invasive cervical carcinomas in Bulgaria.
Todorova I; Ganchev G; Shikova E
J Clin Pathol; 2010 Dec; 63(12):1121-3. PubMed ID: 20943820
[TBL] [Abstract][Full Text] [Related]
8. HPV genotyping from invasive cervical cancer in Chile.
Roa JC; Garcia P; Gomez J; Fernández W; Gaete F; Espinoza A; Lepetic A; Suarez E
Int J Gynaecol Obstet; 2009 May; 105(2):150-3. PubMed ID: 19249046
[TBL] [Abstract][Full Text] [Related]
9. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
Brotherton JM
Vaccine; 2008 Jan; 26(2):250-6. PubMed ID: 18068276
[TBL] [Abstract][Full Text] [Related]
10. [Implementation of HPV vaccination in Germany].
Schreckenberger C; Kaufmann AM; Schneider A
Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
[No Abstract] [Full Text] [Related]
11. Performance of cobas 4800(®) and HPV genotype-specific distribution in opportunistic cervical cancer screening in Madrid.
Mateos-Lindemann ML; Rubio MD; Benito-Berlinches A; Dominguez P
Enferm Infecc Microbiol Clin; 2015 Nov; 33(9):634-5. PubMed ID: 25976752
[No Abstract] [Full Text] [Related]
12. The tango and tangle of human papillomavirus and the human genome.
Burk RD; DeSalle R
J Natl Cancer Inst; 2006 Aug; 98(15):1026-7. PubMed ID: 16882934
[No Abstract] [Full Text] [Related]
13. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India.
Patel KR; Vajaria BN; Begum R; Desai A; Patel JB; Shah FD; Shukla SN; Patel PS
J Oral Pathol Med; 2014 Apr; 43(4):293-7. PubMed ID: 24372728
[TBL] [Abstract][Full Text] [Related]
14. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
[TBL] [Abstract][Full Text] [Related]
15. Early impact of the Japanese immunization program implemented before the HPV vaccination crisis.
Matsumoto K; Yaegashi N; Iwata T; Yamamoto K; Nagashima M; Saito T; Ushijima K; Takahashi F; Noda K; Yoshikawa H
Int J Cancer; 2017 Oct; 141(8):1704-1706. PubMed ID: 28657110
[No Abstract] [Full Text] [Related]
16. High-risk human papillomavirus cervical infections among healthy women in Guadeloupe.
Cordel N; Ragin C; Trival M; Tressières B; Janky E
Int J Infect Dis; 2015 Dec; 41():13-6. PubMed ID: 26597118
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of the etiological structure of sexually transmitted infections and immunological responsiveness in women with papillomavirus infection of the cervix uteri].
Shevchenko EA; Uspenskaia OA
Vopr Virusol; 2009; 54(4):37-9. PubMed ID: 19708554
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus testing for primary cervical cancer screening: is it time to abandon Papanicolaou testing?
Feldman S
JAMA Intern Med; 2014 Oct; 174(10):1539-40. PubMed ID: 25069413
[No Abstract] [Full Text] [Related]
19. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.
Alemany L; Pérez C; Tous S; Llombart-Bosch A; Lloveras B; Lerma E; Guarch R; Andújar M; Pelayo A; Alejo M; Ordi J; Klaustermeier J; Velasco J; Guimerà N; Clavero O; Castellsagué X; Quint W; Muñoz N; Bosch FX; de Sanjosé S;
Gynecol Oncol; 2012 Mar; 124(3):512-7. PubMed ID: 22119990
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus genotype distributions inform screening and vaccination policy.
Pinkowish MD
CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300
[No Abstract] [Full Text] [Related]
[Next] [New Search]
